As of April 2026, it remains on the Category 2 restricted compounding list pending the July advisory panel review
The WeightWatchers GLP-1 Program helps members establish and adhere to healthy habits while the food noise from GLP-1 medications is reduced.
Mosley RL, Benner EJ, Kadiu I, Thomas M, Boska MD, Hasan K, Laurie C, Gendelman HE
mBio 15 , e0305723 (2024)
Long-acting GLP-1 RAs demonstrate significant reductions in fasting plasma glucose by stimulating glucose-dependent insulin secretion, and short-acting agents show substantial decreases in postprandial glucose mainly due to slow gastric emptying [26]
This approach has the advantage that it integrates the effect of both genetic background and nutritional status of the cells in evaluating disease susceptibility